KMTS Financials
Kestra Medical Technologies Ltd - Financial statements & key metrics
Stock Price
$19.97
Market Cap
$1.10B
EPS
$-5.73
Income Statement Highlights
Most Recent Quarter: 2025-04-30
Revenue
$59.81M
Gross Profit
-
Operating Income
-
Net Income
$-113.81M
EPS (Diluted)
$-5.13
Balance Sheet Highlights
Total Assets
$295.74M
Total Liabilities
$90.34M
Shareholders Equity
-
Cash & Equivalents
$237.59M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-77.61M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
48.8%
Operating Margin
-1.4%
Net Margin
-1.7%
ROE
-0.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KMTS revenue?
KMTS's most recent quarterly revenue was $59.81M. Annual revenue can be calculated by summing the four most recent quarters.
Is KMTS profitable?
KMTS reported a loss of $113.81M in the most recent quarter. The net profit margin is -1.7%.
What is KMTS market cap?
KMTS has a market capitalization of $1.10B, making it a small-cap stock.
Does KMTS have debt?
View KMTS's balance sheet for debt information.
What is KMTS cash flow?
Cash flow data is available in the full financial statements.